• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用16S rRNA测序技术探索肠道和尿液微生物群与前列腺疾病(包括良性前列腺增生和前列腺癌)之间的关联。

Exploring the Association between Gut and Urine Microbiota and Prostatic Disease including Benign Prostatic Hyperplasia and Prostate Cancer Using 16S rRNA Sequencing.

作者信息

Tsai Kai-Yen, Wu Deng-Chyang, Wu Wen-Jeng, Wang Jiunn-Wei, Juan Yung-Shun, Li Ching-Chia, Liu Chung-Jung, Lee Hsiang-Ying

机构信息

Department of Post-Baccalaureate Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.

Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.

出版信息

Biomedicines. 2022 Oct 23;10(11):2676. doi: 10.3390/biomedicines10112676.

DOI:10.3390/biomedicines10112676
PMID:36359196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9687995/
Abstract

Numerous microorganisms residing in the gastrointestinal and genitourinary tracts affect host health. We investigated stool and voided urine samples collected from patients with benign prostatic hyperplasia (BPH) or prostate cancer (PC) and a control group to explore the potential relationship between human microbiota and prostatic disease, and aimed to identify correlations and pathogenic taxonomic units. We studied microbial composition using 16S rRNA sequencing to identify operational taxonomic units (OTUs). Extracted genome was amplified and filtered sequences were used to classify OTUs based on their specific taxonomy. No statistically significant differences were observed in stool samples among the groups. However, urine samples indicated different microbiota compositions in different patient populations. The top five microbial genera that showed significant differences between the BPH and control groups were , , , , and . , , , , and were the genera with the largest proportion differences when comparing the PC and control groups. We discovered that the urine microbiota composition of the BPH and PC groups was distinct from that of the control group. Due to the impact of microbiota on prostatic disease, it is necessary to identify specific microbes for further research.

摘要

许多存在于胃肠道和泌尿生殖道的微生物会影响宿主健康。我们调查了从良性前列腺增生(BPH)或前列腺癌(PC)患者以及对照组收集的粪便和尿液样本,以探索人类微生物群与前列腺疾病之间的潜在关系,旨在确定相关性和致病分类单元。我们使用16S rRNA测序研究微生物组成,以识别操作分类单元(OTU)。提取的基因组被扩增,过滤后的序列用于根据其特定分类法对OTU进行分类。各组粪便样本中未观察到统计学上的显著差异。然而,尿液样本表明不同患者群体中的微生物群组成不同。在BPH组和对照组之间显示出显著差异的前五个微生物属是 、 、 、 和 。在比较PC组和对照组时, 、 、 、 和 是比例差异最大的属。我们发现BPH组和PC组的尿液微生物群组成与对照组不同。由于微生物群对前列腺疾病的影响,有必要识别特定微生物以进行进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/e53db1b7ce48/biomedicines-10-02676-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/34332749b288/biomedicines-10-02676-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/08009c94ba45/biomedicines-10-02676-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/8d2b21b0518b/biomedicines-10-02676-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/722cd60f76ac/biomedicines-10-02676-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/ec424970c2d7/biomedicines-10-02676-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/3c1c62d15417/biomedicines-10-02676-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/8c0bae9bc16e/biomedicines-10-02676-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/0473b66034d2/biomedicines-10-02676-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/e53db1b7ce48/biomedicines-10-02676-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/34332749b288/biomedicines-10-02676-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/08009c94ba45/biomedicines-10-02676-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/8d2b21b0518b/biomedicines-10-02676-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/722cd60f76ac/biomedicines-10-02676-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/ec424970c2d7/biomedicines-10-02676-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/3c1c62d15417/biomedicines-10-02676-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/8c0bae9bc16e/biomedicines-10-02676-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/0473b66034d2/biomedicines-10-02676-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d91/9687995/e53db1b7ce48/biomedicines-10-02676-g009.jpg

相似文献

1
Exploring the Association between Gut and Urine Microbiota and Prostatic Disease including Benign Prostatic Hyperplasia and Prostate Cancer Using 16S rRNA Sequencing.利用16S rRNA测序技术探索肠道和尿液微生物群与前列腺疾病(包括良性前列腺增生和前列腺癌)之间的关联。
Biomedicines. 2022 Oct 23;10(11):2676. doi: 10.3390/biomedicines10112676.
2
The impact of urine microbiota in patients with lower urinary tract symptoms.尿液微生物组对下尿路症状患者的影响。
Ann Clin Microbiol Antimicrob. 2021 Apr 15;20(1):23. doi: 10.1186/s12941-021-00428-9.
3
Alterations of gut microbiota diversity, composition and metabonomics in testosterone-induced benign prostatic hyperplasia rats.睾酮诱导的良性前列腺增生大鼠肠道微生物多样性、组成和代谢组学的改变。
Mil Med Res. 2022 Mar 28;9(1):12. doi: 10.1186/s40779-022-00373-4.
4
A prospective study to examine the association of the urinary and fecal microbiota with prostate cancer diagnosis after transrectal biopsy of the prostate using 16sRNA gene analysis.一项前瞻性研究,通过16sRNA基因分析来检测经直肠前列腺活检后前列腺癌诊断与尿液和粪便微生物群之间的关联。
Prostate. 2019 Jan;79(1):81-87. doi: 10.1002/pros.23713. Epub 2018 Aug 16.
5
Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.基于粪便代谢组学联合 16S rRNA 基因测序分析肾阳虚证大鼠肠道菌群变化及右归丸的干预作用
J Ethnopharmacol. 2019 Nov 15;244:112139. doi: 10.1016/j.jep.2019.112139. Epub 2019 Aug 8.
6
Metagenomic identification of gut microbiota distribution on the colonic mucosal biopsy samples in patients with non-alcoholic fatty liver disease.基于宏基因组学的非酒精性脂肪性肝病患者结肠黏膜活检样本肠道微生物菌群分布分析
Gene. 2022 Jul 30;833:146587. doi: 10.1016/j.gene.2022.146587. Epub 2022 May 19.
7
High-Fat Diet Induced Gut Microbiota Alterations Associating With Ghrelin/Jak2/Stat3 Up-Regulation to Promote Benign Prostatic Hyperplasia Development.高脂饮食诱导肠道微生物群改变,与胃饥饿素/Jak2/Stat3上调相关,促进良性前列腺增生发展。
Front Cell Dev Biol. 2021 Jun 24;9:615928. doi: 10.3389/fcell.2021.615928. eCollection 2021.
8
[Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].[16S核糖体RNA高通量测序技术分析特重度烧伤患者肠道微生物群的动态变化]
Zhonghua Shao Shang Za Zhi. 2020 Dec 20;36(12):1159-1166. doi: 10.3760/cma.j.cn501120-20200518-00271.
9
The effect of the urinary and faecal microbiota on lower urinary tract symptoms measured by the International Prostate Symptom Score: analysis utilising next-generation sequencing.利用下一代测序技术分析尿和粪便微生物群对国际前列腺症状评分(IPSS)测量的下尿路症状的影响。
BJU Int. 2020 Jun;125(6):905-910. doi: 10.1111/bju.14972. Epub 2020 May 4.
10
Escherichia coli, a common constituent of benign prostate hyperplasia-associated microbiota induces inflammation and DNA damage in prostate epithelial cells.大肠杆菌是良性前列腺增生相关微生物群的常见组成部分,可诱导前列腺上皮细胞炎症和 DNA 损伤。
Prostate. 2020 Nov;80(15):1341-1352. doi: 10.1002/pros.24063. Epub 2020 Aug 24.

引用本文的文献

1
Prostate and urinary microbiomes in prostate cancer development: focus on .前列腺癌发展中的前列腺和泌尿微生物群:聚焦于…… (原文似乎不完整)
Front Cell Infect Microbiol. 2025 May 21;15:1562729. doi: 10.3389/fcimb.2025.1562729. eCollection 2025.
2
Identification of an intestinal microbiota enterotypes in ageing man diagnosed with benign prostatic hyperplasia (BPH).在被诊断为良性前列腺增生(BPH)的老年男性中鉴定肠道微生物群肠型。
Sci Rep. 2025 May 4;15(1):15603. doi: 10.1038/s41598-025-00466-9.
3
Genitourinary microbiomes and prostate cancer: a systematic review and meta-analysis of tumorigeneses and cancer characteristics.

本文引用的文献

1
Diet, Probiotics and Physical Activity: The Right Allies for a Healthy Microbiota.饮食、益生菌和体育活动:健康微生物组的得力盟友。
Anticancer Res. 2021 Jun;41(6):2759-2772. doi: 10.21873/anticanres.15057.
2
A cross-sectional study on gut microbiota in prostate cancer patients with prostatectomy or androgen deprivation therapy.一项关于接受前列腺切除术或雄激素剥夺治疗的前列腺癌患者肠道微生物群的横断面研究。
Prostate Cancer Prostatic Dis. 2021 Dec;24(4):1063-1072. doi: 10.1038/s41391-021-00360-1. Epub 2021 Apr 13.
3
Cancer Statistics, 2021.癌症统计数据,2021.
泌尿生殖微生物群与前列腺癌:肿瘤发生及癌症特征的系统评价与荟萃分析
Cent European J Urol. 2024;77(3):447-455. doi: 10.5173/ceju.2024.80. Epub 2024 Jun 18.
4
Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to Detection and Risk Stratification.前列腺癌临床与实验生物标志物的当代进展:一种聚焦多组学的检测与风险分层方法
Biology (Basel). 2024 Sep 25;13(10):762. doi: 10.3390/biology13100762.
5
Causality investigation among gut microbiota, immune cells, and prostate diseases: a Mendelian randomization study.肠道微生物群、免疫细胞与前列腺疾病之间的因果关系研究:一项孟德尔随机化研究
Front Microbiol. 2024 Sep 11;15:1445304. doi: 10.3389/fmicb.2024.1445304. eCollection 2024.
6
Exploring the potential mechanism of Xiaojin Pill therapy for benign prostatic hyperplasia through metabolomics and gut microbiota analysis.通过代谢组学和肠道微生物群分析探索小金丸治疗良性前列腺增生的潜在机制。
Front Microbiol. 2024 Aug 21;15:1431954. doi: 10.3389/fmicb.2024.1431954. eCollection 2024.
7
Intrinsic and extrinsic factors causing hyperplasia of the prostate.导致前列腺增生的内在和外在因素。
Int J Urol. 2024 Jul;31(7):705-717. doi: 10.1111/iju.15446. Epub 2024 Mar 10.
8
Impact of coexisting type 2 diabetes mellitus on the urinary microbiota of kidney stone patients.共存 2 型糖尿病对肾结石患者尿液微生物群的影响。
PeerJ. 2024 Feb 26;12:e16920. doi: 10.7717/peerj.16920. eCollection 2024.
9
Associations between gut microbiota and three prostate diseases: a bidirectional two-sample Mendelian randomization study.肠道微生物群与三种前列腺疾病的关联:一项双向两样本孟德尔随机化研究。
Sci Rep. 2024 Feb 18;14(1):4019. doi: 10.1038/s41598-024-54293-5.
10
Gut Microbiota Disorders in Obesity-Associated Benign Prostatic Hyperplasia in Rats.大鼠肥胖相关良性前列腺增生中的肠道微生物群紊乱
Biochem Genet. 2024 Dec;62(6):4639-4653. doi: 10.1007/s10528-023-10634-z. Epub 2024 Feb 13.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
4
The effect of the urinary and faecal microbiota on lower urinary tract symptoms measured by the International Prostate Symptom Score: analysis utilising next-generation sequencing.利用下一代测序技术分析尿和粪便微生物群对国际前列腺症状评分(IPSS)测量的下尿路症状的影响。
BJU Int. 2020 Jun;125(6):905-910. doi: 10.1111/bju.14972. Epub 2020 May 4.
5
The microbiome and cancer for clinicians.微生物组与癌症:临床医师视角
Crit Rev Oncol Hematol. 2019 Sep;141:1-12. doi: 10.1016/j.critrevonc.2019.06.004. Epub 2019 Jun 8.
6
Urologist Practice Structure and Spending for Prostate Cancer Care.泌尿科医生的实践结构和前列腺癌治疗的支出。
Urology. 2019 Aug;130:65-71. doi: 10.1016/j.urology.2019.03.029. Epub 2019 Apr 25.
7
The role of microbiota in the development of colorectal cancer.肠道微生物群在结直肠癌发展中的作用。
Int J Cancer. 2019 Oct 15;145(8):2032-2041. doi: 10.1002/ijc.32017. Epub 2019 Jan 15.
8
Male Bladder Microbiome Relates to Lower Urinary Tract Symptoms.男性膀胱微生物群与下尿路症状相关。
Eur Urol Focus. 2020 Mar 15;6(2):376-382. doi: 10.1016/j.euf.2018.08.001. Epub 2018 Aug 22.
9
Microbiota and metabolic diseases.微生物群与代谢性疾病。
Endocrine. 2018 Sep;61(3):357-371. doi: 10.1007/s12020-018-1605-5. Epub 2018 May 2.
10
Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer.对前列腺癌活检结果为阳性和阴性的男性的尿液微生物群进行分析。
J Urol. 2018 Jan;199(1):161-171. doi: 10.1016/j.juro.2017.08.001. Epub 2017 Aug 7.